Tito Bastianello Young Investigator Awards will be presented to the top
presentations during The Best of Abstracts Session on Saturday, May 11, 2019.
Winners will receive an award and announced with a silver plaque during the session.
Scientific Committee will nominate four candidates worthy of receiving
the award. Therefore, four Tito Bastianello Young Investigator
Awards will be granted at MDS 20197 in Copenhagen.
IN REMEMBERANCE OF TITO BASTIANELLO
Tito Bastianello was born in Venice, Italy, in August 1930.
graduating in Law, he started working in the family business. In 1958
he went on to establish his own company, founding one of the first
chains of supermarkets in Italy. He engaged in social, cultural and
non-profit activities, holding important offices and contributing to
the development of the many different entities he was involved with.
his lifetime he was faced with difficult challenges, both in his
business and in dealing with his health, having to undergo coronary
bypass surgery following a severe heart attack in 1993.
In 2001 he
was diagnosed with MDS, and he was told that at that time there were
no drugs which could counter the disease. He accepted the diagnosis with
equanimity, but with the determination not to give in, and therefore
to explore all the possibilities available at that time the world over,
as he had enormous confidence in the power of scientific research.
in 2004 the effectiveness of azacitidine was confirmed, he went first
to the U.S. and then to Germany, in the hope of being admitted to
treatment with azacitidine or decitabine, but both his attempts
In autumn 2004 the FDA approved the new drug,
and in Italy some departments of Hematology were allowed to use
azacitidine. Although his disease had turned to AML, he asked to be
treated with the new drug, which however was not yet readily available
in Italian hospitals. With many difficulties, he eventually managed to
get it from the U.S.
He could not beat the disease. He knew that
his battle was lost. Nevertheless, being treated with a new drug which,
thanks to research, could give hope to MDS patients, was for him an
achievement in itself.
He passed away in September 2005.